Related Experiment Video
Updated: Sep 3, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Atrial fibrillation: epidemiology and the risk and prevention of stroke
1Austin Hospital, Heidelberg, Victoria, Australia.
Insights
Atrial fibrillation increases stroke risk, particularly in nonrheumatic cases. Warfarin prophylaxis is now supported by recent studies for these patients, though aspirin
Area of Science:
- Cardiology
- Neurology
- Epidemiology
Background:
- Atrial fibrillation (AF) incidence rises with age, with congestive cardiac failure, coronary artery disease, and hypertension now more commonly associated than rheumatic heart disease.
- Nonrheumatic AF significantly elevates ischemic stroke risk (approx. 5-fold) and yearly stroke risk (5-7%), increasing with age.
- AF is linked to silent cerebral infarction and increased mortality, but its independent association with stroke risk remains debated.
Purpose of the Study:
- To review the evolving understanding of atrial fibrillation (AF) and its associated conditions.
- To evaluate the evidence supporting preventive therapies for stroke in nonrheumatic AF.
- To discuss risk stratification and the role of antithrombotic prophylaxis in AF management.
Main Methods:
- Review of recent prospective randomized studies on warfarin prophylaxis in nonrheumatic AF.
- Analysis of epidemiological data on AF prevalence and associated cardiovascular conditions.
- Synthesis of literature regarding stroke risk, silent cerebral infarction, and mortality in AF patients.
Main Results:
- Four recent prospective randomized studies provide clear support for warfarin prophylaxis in nonrheumatic AF.
- Identification of high- and low-risk subgroups within nonrheumatic AF patients may guide prophylaxis decisions.
- Contradictory findings persist in the literature regarding risk stratification and the role of aspirin for prophylaxis.
Conclusions:
- Warfarin prophylaxis is recommended for nonrheumatic atrial fibrillation based on current evidence.
- Further research is needed to clarify risk stratification and the role of aspirin in AF stroke prevention.
Abstract:
Atrial fibrillation is a common disorder and the incidence increases with each decade of life. Previously, rheumatic mitral valve disease has been the condition most highly associated with atrial fibrillation. However, with the decreasing incidence of rheumatic heart disease, other conditions have assumed greater importance and now congestive cardiac failure, coronary artery disease, and hypertension are the most commonly associated conditions. Nonrheumatic atrial fibrillation is associated with an approximately five-fold increase in the risk of ischemic stroke and a 5% to 7% yearly risk that increases with age. In addition, atrial fibrillation is associated with an increased incidence of silent cerebral infarction and increased mortality. However, whether atrial fibrillation is independently associated with the risk of stroke or is a marker of underlying cardiac disease is contentious. Until recently, the use of preventive therapy has been controversial. However, data from four recently published, prospective randomized studies clearly support the use of warfarin prophylaxis in nonrheumatic atrial fibrillation. Within the diverse group of patients with nonrheumatic atrial fibrillation there are high and low risk subgroups and identification of these may influence decisions regarding antithrombotic prophylaxis. With a few exceptions, however, this remains an area in which there are contradictory findings in the literature. The role of aspirin for prophylaxis in nonrheumatic atrial fibrillation remains unclear and further evaluation awaits the publication of ongoing studies.
More Related Videos
Related Concept Videos
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Dysrhythmias VI: Management of Dysrhythmias
Venous Thrombosis III: Interprofessional Care
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Ischemic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology

